435 related articles for article (PubMed ID: 25795009)
21. Untargeted serum metabolomics reveals novel metabolite associations and disruptions in amino acid and lipid metabolism in Parkinson's disease.
Paul KC; Zhang K; Walker DI; Sinsheimer J; Yu Y; Kusters C; Del Rosario I; Folle AD; Keener AM; Bronstein J; Jones DP; Ritz B
Mol Neurodegener; 2023 Dec; 18(1):100. PubMed ID: 38115046
[TBL] [Abstract][Full Text] [Related]
22. Serum metabolomics analysis revealed metabolic disorders in Parkinson's disease.
Lan TT; Chang L; Hou LW; Wang ZZ; Li DC; Ren ZH; Gu T; Wang JW; Chen GS
Medicine (Baltimore); 2023 Jun; 102(23):e33715. PubMed ID: 37335671
[TBL] [Abstract][Full Text] [Related]
23. Increased bilirubin levels in de novo Parkinson's disease.
Moccia M; Picillo M; Erro R; Longo K; Amboni M; Santangelo G; Palladino R; Allocca R; Caporale O; Triassi M; Pellecchia MT; Barone P; Vitale C
Eur J Neurol; 2015 Jun; 22(6):954-9. PubMed ID: 25740378
[TBL] [Abstract][Full Text] [Related]
24. Cerebral metabonomics study on Parkinson's disease mice treated with extract of Acanthopanax senticosus harms.
Li XZ; Zhang SN; Lu F; Liu CF; Wang Y; Bai Y; Wang N; Liu SM
Phytomedicine; 2013 Oct; 20(13):1219-29. PubMed ID: 23830815
[TBL] [Abstract][Full Text] [Related]
25. Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
Fujimaki M; Saiki S; Li Y; Kaga N; Taka H; Hatano T; Ishikawa KI; Oji Y; Mori A; Okuzumi A; Koinuma T; Ueno SI; Imamichi Y; Ueno T; Miura Y; Funayama M; Hattori N
Neurology; 2018 Jan; 90(5):e404-e411. PubMed ID: 29298852
[TBL] [Abstract][Full Text] [Related]
26. Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study.
Bakshi R; Macklin EA; Hung AY; Hayes MT; Hyman BT; Wills AM; Gomperts SN; Growdon JH; Ascherio A; Scherzer CR; Schwarzschild MA
J Parkinsons Dis; 2020; 10(2):505-510. PubMed ID: 32250320
[TBL] [Abstract][Full Text] [Related]
27. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
28. Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson's disease: the SPIN-PD study.
Ravina B; Eberly S; Oakes D; Lang AE; Dodelet V; Roos P; Harman J; Shoulson I; Schipper HM
Biomark Med; 2015; 9(2):89-97. PubMed ID: 25689898
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic metabolomic profiling of Parkinson's disease biospecimens.
LeWitt PA; Li J; Wu KH; Lu M
Neurobiol Dis; 2023 Feb; 177():105962. PubMed ID: 36563791
[TBL] [Abstract][Full Text] [Related]
30. Plasma acyl-carnitines, bilirubin, tyramine and tetrahydro-21-deoxycortisol in Parkinson's disease and essential tremor. A case control biomarker study.
Albillos SM; Montero O; Calvo S; Solano-Vila B; Trejo JM; Cubo E
Parkinsonism Relat Disord; 2021 Oct; 91():167-172. PubMed ID: 34649109
[TBL] [Abstract][Full Text] [Related]
31. Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease.
Shao Y; Le W
Mol Neurodegener; 2019 Jan; 14(1):3. PubMed ID: 30634989
[TBL] [Abstract][Full Text] [Related]
32. Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
Dong MX; Hu L; Wei YD; Chen GH
Neurosci Lett; 2021 Feb; 745():135626. PubMed ID: 33440238
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
Posavi M; Diaz-Ortiz M; Liu B; Swanson CR; Skrinak RT; Hernandez-Con P; Amado DA; Fullard M; Rick J; Siderowf A; Weintraub D; McCluskey L; Trojanowski JQ; Dewey RB; Huang X; Chen-Plotkin AS
PLoS Med; 2019 Oct; 16(10):e1002931. PubMed ID: 31603904
[TBL] [Abstract][Full Text] [Related]
34. Study of metabolic disorders associated with BDE-47 exposure in Drosophila model by MS-based metabolomics.
Ji F; Wei J; Luan H; Li M; Cai Z
Ecotoxicol Environ Saf; 2019 Nov; 184():109606. PubMed ID: 31472382
[TBL] [Abstract][Full Text] [Related]
35. Alterations in Lipid and Inositol Metabolisms in Two Dopaminergic Disorders.
Schulte EC; Altmaier E; Berger HS; Do KT; Kastenmüller G; Wahl S; Adamski J; Peters A; Krumsiek J; Suhre K; Haslinger B; Ceballos-Baumann A; Gieger C; Winkelmann J
PLoS One; 2016; 11(1):e0147129. PubMed ID: 26808974
[TBL] [Abstract][Full Text] [Related]
36. Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets.
de Farias CC; Maes M; Bonifácio KL; Bortolasci CC; de Souza Nogueira A; Brinholi FF; Matsumoto AK; do Nascimento MA; de Melo LB; Nixdorf SL; Lavado EL; Moreira EG; Barbosa DS
Neurosci Lett; 2016 Mar; 617():66-71. PubMed ID: 26861200
[TBL] [Abstract][Full Text] [Related]
37. A Simultaneous Metabolic Profiling and Quantitative Multimetabolite Metabolomic Method for Human Plasma Using Gas-Chromatography Tandem Mass Spectrometry.
Savolainen OI; Sandberg AS; Ross AB
J Proteome Res; 2016 Jan; 15(1):259-65. PubMed ID: 26615962
[TBL] [Abstract][Full Text] [Related]
38. Novel biomarker for neurodegenerative diseases- motor neuron disease (MND), cerebellar ataxia (CA) and Parkinson's disease (PD).
Pandey S; Singh B; Yadav SK; Mahdi AA
Clin Chim Acta; 2018 Oct; 485():258-261. PubMed ID: 30006282
[TBL] [Abstract][Full Text] [Related]
39. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
40. Mass Spectrometric Methodologies for Investigating the Metabolic Signatures of Parkinson's Disease: Current Progress and Future Perspectives.
Gill EL; Koelmel JP; Yost RA; Okun MS; Vedam-Mai V; Garrett TJ
Anal Chem; 2018 Mar; 90(5):2979-2986. PubMed ID: 29384654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
